An alternate conformation of HCV E2 neutralizing face as an additional vaccine target

To achieve global elimination of hepatitis C virus (HCV), an effective cross-genotype vaccine is needed. The HCV envelope glycoprotein E2 is the main target for neutralizing antibodies (nAbs), which aid in HCV clearance and protection. E2 is structurally flexible and functions in engaging host recep...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Adv
Main Authors: Tzarum, Netanel, Giang, Erick, Kadam, Rameshwar U., Chen, Fang, Nagy, Kenna, Augestad, Elias H., Velázquez-Moctezuma, Rodrigo, Keck, Zhen-Yong, Hua, Yuanzi, Stanfield, Robyn L., Dreux, Marlene, Prentoe, Jannick, Foung, Steven K. H., Bukh, Jens, Wilson, Ian A., Law, Mansun
Formato: Artigo
Idioma:Inglês
Publicado em: American Association for the Advancement of Science 2020
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7380959/
https://ncbi.nlm.nih.gov/pubmed/32754640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.abb5642
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados